Studies were carried out to analyze the antigenicity of Soluble Protective Antigen (SPA) separated from culture supernatant fluids of Salmonella enteritidis strain 2547. Mice injected with anti-SPA mouse serum were capable of tolerating a challenge dose of 100 LD50 S. enteritidis. After absorption of the anti-SPA mouse serum with lipopolysaccharide (LPS) prepared from strain 2547, no protective effect was observed. Ouchterlony immunodiffusion analysis showed that the P1 fraction obtained from Sephadex G-50 gel filtration of strain 2547 or 2822 LPS reacted with antiserum to SPA, but no reaction was observed with the P2 or P3 fraction. The LPS from strain 2547 gave 80% mouse protection against challenge with 100 LD50 of the homologous bacteria, while the P1 from strain 2547 LPS afforded 40% protective immunity. When P1, LPS and SPA were transferred into the footpad of SPA-immunized mice, a positive delayed footpad reaction was elicited. Similarly, macrophage migration inhibitory activity was observed when SPA-induced peritoneal exudate cells were cultured in medium containing P1, LPS and SPA. These results suggest that the antigenic determinatant of SPA exists in the O-antigenic components of LPS.
Introduction
Mouse infections with Salmonella enteritidis have been studied as a model of human typhoid infection. It has been generally accepted that antigen-specific T lymphocytes play the major role in the development of immunity to intracelluar bacterial parasites1). Several investigators have shown that effective resistance to S. enteritidis, one of the facultative intracellular bacteria, is based on cell-mediated immunity induced only by live vaccine2)3). However, there are many reports showing that non-viable vaccine is effective against Salmonella infection4)5). Plant et al.6) reported that a supernatant factor prepared from cultures of S. typhimurium protects mice against a subcutaneous challenge dose of 100 LD50 S. typhimurium. In this laboratory it has been shown that mice immunized by a single injection of Soluble Protective Antigen (SPA) separated from the culture fluids of S. enteritidis strain 2547 tolerated a challenge against 10,000 LD50 of the same organism strain7), and that both cellular and humoral immune responses are significant in this protective mechanism8)9). In previous studies, chemical analysis of SPA confirmed the presence of lauric, myristic, palmitic and 3-hydroxymyristic acid which are common constituents of the lipid A moiety. Furthermore, SPA enhanced both the plaque-forming cell (PFC)-response to sheep erythrocytes and the clotting activity of Limulus amebocyte lysate (unpublished data). These results indicated that SPA possesses the properties of LPS extracted from bacteria by chemical methods. 16 ) demonstrated that liberation of lipopolysaccharide was due to solubilization or shedding of preexisting cell wall material, and not a consequence of metabolic overproduction of this material; nor was it a result of cellular lysis. Previous studies have shown that SPA contains a lipid A moiety, and possesses the properties of LPS extracted from bacteria by chemical procedures. The conclusion from these results is that SPA is part of the LPS that is released into the liquid environment as a result of the solubilization of bacterial cell wall material; and is composed of lipid A and core material. However, SPA alone can induce significant protection against the challenge of 10,000 LD50 of S. enteritidis strain 2547. LPS and P1 from strain 2547 only afforded 80% and 40% protective immunity against the challenge of 100 LD50 of homologous bacteria. Although SPA is certainly part of the LPS that is released into the liquid environemnt, it seems that the physiochemical capabilities of the SPA differs markedly from the LPS isolated by chemical procedures.
